Medical technology company Xtant Medical Holdings has completed the acquisition of the Coflex and Cofix product portfolio from Surgalign Holdings for $17m.

The entities signed a definitive agreement on 28 February in this regard.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Serving as a non-fusion treatment option for lumbar spinal stenosis (LSS) patients, Coflex is an interlaminar stabilisation device that can be used following open decompression in several settings.

According to the company, the number of patients diagnosed with LSS across the globe is around 2.4 million, which is considered to be the largest single-growing spine patient demographic.

Claimed to be the only implant with US Food and Drug Administration (FDA) premarket approval (PMA), the Coflex device has already been implanted in more than 200,000 patients in over 60 countries.

The device, which is clinically validated in more than 90 peer-reviewed publications, comes under Ambulatory Surgery Center (ASC) reimbursement.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Meanwhile, Cofix is a minimally invasive supplemental fixation device meant for use on all levels of the lumbar spine.

Xtant Medical president and CEO Sean Browne said: “Coupled with our less invasive Axle interspinous device and Silex SI Fusion product lines, Coflex augments our offering in the fast-growing segments of ASC and outpatient procedures. 

“Aligning with our key growth pillars, this acquisition expands our footprint by adding new distributors and a significant number of trained surgeons to the Company’s network.”

Surgalign president and CEO Terry Rich said: “This transaction provides us with non-dilutive capital, which will be used to advance our leading platform of artificial intelligence products across the entire continuum of care.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact